Amgen Stock Has Surged. Here’s Where It’s Headed Next.
All of a sudden, Amgen stock is up 15% since late December to around $299. Its rise helped push up the healthcare sector up ...
Hosted on MSN15h
Amgen Earnings Transcript (NASDAQ:AMGN)
Presentation Unidentified Speaker Thank you. Thank you, Julianne. Good afternoon, everyone, and welcome to our 4th-quarter ...
Amgen price target raised to $275 from $256 at BofA
BofA raised the firm’s price target on Amgen (AMGN) to $275 from $256 and keeps an Underperform rating on the shares. Q4 results were slightly ...
Amgen upgraded to Buy from Hold at Erste Group
Erste Group analyst Hans Engel upgraded Amgen (AMGN) to Buy from Hold. Amgen has a higher operating margin and a higher return on equity than ...
Febrile Neutropenia Clinical Trials Review 2024, by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
The "Febrile Neutropenia - Global Clinical Trials Review, 2024" report has been added to ResearchAndMarkets.com's offering.The clinical trials report provides an overview of the Febrile Neutropenia ...
News Medical6d
An Arm and a Leg: The ‘Shkreli Awards’ — for dysfunction and profiteering in health care
Every year, a health care think tank called the Lown Institute ranks the 10 worst examples of "profiteering and dysfunction" ...